Form 4 for ONCO Onconetix, Inc.
Accepted 2025-01-22 00:00:00 ET · period of report 2024-12-20 · accession 0001213900-25-005491 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2024-12-20 | ONCO | Bruhlmann Christian | Chief Strategy Off | A - Grant | $0.00 | +177.5K | 611.4K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-20 | A | A | 177,462 | $0.00 | 611,372 | D | — | — | (F1) Represents shares of Common Stock of the Issuer issuable upon settlement of Restricted Stock Units. |